Marked prolongation of QRS duration after initiation of dronedarone therapy

Marked prolongation of QRS duration after initiation of dronedarone therapy

Dronedarone is a relatively new antiarrhythmic drug and is held to be less proarrhythmic than comparable compounds, although its proarrhythmia potential in humans has not been sufficiently evaluated. We describe a so far unreported dronedarone effect, namely a significant alteration of both the morp...

Full description

Bibliographic Details
Main Authors: Conrad Genz, Hans D. Esperer, Alexander Schmeisser, Ruediger C. Braun-Dullaeus, Samir M. Said
Format: Article
Language:English
Published: Touch Medical Media 2014-08-01
Series:Heart International
Subjects:
Adverse drug events
Antiarrhythmic drugs
Atrial fibrillation
Dronedarone
Online Access:http://www.heart-int.com/article/marked-prolongation-of-qrs-duration-after-initiation-of-dronedarone-therapy

Internet

http://www.heart-int.com/article/marked-prolongation-of-qrs-duration-after-initiation-of-dronedarone-therapy

Similar Items